Literature DB >> 28886759

Epigenetic Regulation of the Kappa Opioid Receptor by Child Abuse.

Pierre-Eric Lutz1, Jeffrey A Gross1, Sabine K Dhir2, Gilles Maussion1, Jennie Yang1, Alexandre Bramoulle1, Michael J Meaney2, Gustavo Turecki3.   

Abstract

BACKGROUND: Experiences of abuse and neglect during childhood are major predictors of the emergence of depressive and suicidal behaviors throughout life. The underlying biological mechanisms, however, remain poorly understood. Here, we focused on the opioid system as a potential brain substrate mediating these effects.
METHODS: Postmortem samples from three brain structures regulating social bonds and emotions were analyzed. Groups were constituted of depressed individuals who died by suicide, with or without a history of severe child abuse, and of psychiatrically healthy control subjects. Expression of opioid peptides and receptors was measured using real-time polymerase chain reaction. DNA methylation, a major epigenetic mark, was investigated using targeted bisulfite sequencing and characterized at functional level using in vitro reporter assays. Finally, oxidative bisulfite sequencing was used to differentiate methylation and hydroxymethylation of DNA.
RESULTS: A history of child abuse specifically associated in the anterior insula with a downregulation of the kappa opioid receptor (Kappa), as well as decreased DNA methylation in the second intron of the Kappa gene. In vitro assays further showed that this intron functions as a genomic enhancer where glucocorticoid receptor binding regulates Kappa expression, unraveling a new mechanism mediating the well-established interactions between endogenous opioids and stress. Finally, results showed that child abuse is associated in the Kappa intron with a selective reduction in levels of DNA hydroxymethylation, likely mediating the observed downregulation of the receptor.
CONCLUSIONS: Altogether, our findings uncover new facets of Kappa physiology, whereby this receptor may be epigenetically regulated by stressful experiences, in particular as a function of early social life.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Child abuse; DNA hydroxymethylation; DNA methylation; Kappa opioid receptor; Postmortem; Reporter assay

Mesh:

Substances:

Year:  2017        PMID: 28886759     DOI: 10.1016/j.biopsych.2017.07.012

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  The Role of Epigenetic Dysregulation in Suicidal Behaviors.

Authors:  Laura M Fiori; Gustavo Turecki
Journal:  Curr Top Behav Neurosci       Date:  2020

Review 2.  The Opioid Crisis and the Future of Addiction and Pain Therapeutics.

Authors:  Nathan P Coussens; G Sitta Sittampalam; Samantha G Jonson; Matthew D Hall; Heather E Gorby; Amir P Tamiz; Owen B McManus; Christian C Felder; Kurt Rasmussen
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

Review 3.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

Review 4.  The role of DNA methylation in the association between childhood adversity and cardiometabolic disease.

Authors:  Guang Hao; Nagy A Youssef; Catherine L Davis; Shaoyong Su
Journal:  Int J Cardiol       Date:  2017-12-24       Impact factor: 4.164

Review 5.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

6.  Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use.

Authors:  Sarah D Lichenstein; Yasmin Zakiniaeiz; Sarah W Yip; Kathleen A Garrison
Journal:  Curr Addict Rep       Date:  2019-04-27

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

8.  The Role of Opiates in Social Pain and Suicidal Behavior.

Authors:  Benedicte Nobile; Pierre-Eric Lutz; Emilie Olie; Philippe Courtet
Journal:  Curr Top Behav Neurosci       Date:  2020

Review 9.  Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.

Authors:  Aiste Lengvenyte; Emilie Olié; Philippe Courtet
Journal:  Curr Psychiatry Rep       Date:  2019-12-03       Impact factor: 5.285

Review 10.  New agents and perspectives in the pharmacological treatment of major depressive disorder.

Authors:  Marsal Sanches; Joao Quevedo; Jair C Soares
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-11-05       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.